High blood pressure (hypertension) affects nearly half of all U.S. adults -- roughly 120 million people -- and is a leading cause of heart disease, stroke, and kidney failure. Excess body weight is one of the strongest modifiable risk factors: each additional 2.2 pounds of body weight increases systolic blood pressure by about 1 mmHg. Many people take multiple blood pressure medications yet still struggle to reach target levels because the underlying weight issue remains unaddressed. The relationship between weight and blood pressure is direct and dose-dependent, meaning greater weight loss leads to greater blood pressure reduction.
GLP-1 treatment for patients with High Blood Pressure. Prescribed by licensed providers, delivered to your door. Compounded medications are not FDA-approved.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · High Blood Pressure is already seeing results
Semaglutide and tirzepatide are the active ingredients in FDA-approved GLP-1 medications (Wegovy®, Zepbound®) whose clinical trials of the FDA-approved brand-name products studied populations that included patients with High Blood Pressure. High Blood Pressure affects approximately Affects nearly half of US adults of U.S. adults. Weight Method offers compounded programs starting at $199/month with virtual consultations and direct shipping. Compounded medications are not FDA-approved.
GLP-1 receptor agonists lower blood pressure through two mechanisms: weight loss itself and direct vascular effects. Studies show that semaglutide reduces systolic blood pressure by 3-6 mmHg on average, with greater reductions in patients who lose more weight. Tirzepatide has demonstrated similar blood pressure benefits in clinical trials. Beyond weight loss, GLP-1 medications appear to improve endothelial function and reduce arterial stiffness. For many patients, this dual benefit means fewer blood pressure medications, lower doses, and better overall cardiovascular protection.
If you have high blood pressure and a BMI of 27 or higher, GLP-1 therapy is a well-supported treatment option. Hypertension is recognized as a weight-related comorbidity that qualifies patients for medical weight management. Weight Method providers evaluate your blood pressure medications and cardiovascular risk profile during your consultation.
Answer a few quick questions to see if you qualify for GLP-1 medication.
Check EligibilityAnswer questions about your health and medical condition.
A provider will review your case and create a personalized plan.
Your GLP-1 medication ships directly to your door.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Find out if GLP-1 medications can help you lose weight with High Blood Pressure.
Get Started NowFree consultation. No commitment.